Development of vaccines for Chagas disease (CRUZIVAX): stakeholders’ preferences and potential impacts on healthcare-Reference-Cited by-同舟云学术

Development of vaccines for Chagas disease (CRUZIVAX): stakeholders’ preferences and potential impacts on healthcare

Published:2023 Issue: Volume:37 Page:102275
ISSN:0213-9111
Container-title:Gaceta Sanitaria
language:en
Short-container-title:Gaceta Sanitaria

Author:

Ramponi Francesco,Aerts Céline,Sartor Paula,Pinazo María Jesús,Freilij Héctor,Guzmán Carlos A.,Malchiodi Emilio,Sicuri Elisa

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health

Reference25 articles.

1. Hunter's Tropical Medicine and Emerging Infectious Diseases. E-Book;Ryan,2019

2. World Health Organization. Chagas disease (American trypanosomiasis). WHO; 2019. Available at: https://www.who.int/es/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis.

3. Chagas disease;Perez-Molina;Lancet.,2018

4. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease;Kratz;Expert Rev Clin Pharmacol.,2018

5. Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection;Sanchez Alberti;npj Vaccines.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei;ACS Infectious Diseases;2024-08-09

2. Trypanosoma cruzi infection: strategies for the development of a vaccine;SCT Proceedings in Interdisciplinary Insights and Innovations;2024-06-12

3. Metacyclogenesis as the Starting Point of Chagas Disease;International Journal of Molecular Sciences;2023-12-21